518 related articles for article (PubMed ID: 26065533)
1. Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.
Penkina A; Semjonov K; Hakola M; Vuorinen S; Repo T; Yliruusi J; Aruväli J; Kogermann K; Veski P; Heinämäki J
Drug Dev Ind Pharm; 2016; 42(3):378-88. PubMed ID: 26065533
[TBL] [Abstract][Full Text] [Related]
2. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
3. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
[TBL] [Abstract][Full Text] [Related]
4. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
5. Electrospun nanofibers as a potential controlled-release solid dispersion system for poorly water-soluble drugs.
Paaver U; Heinämäki J; Laidmäe I; Lust A; Kozlova J; Sillaste E; Kirsimäe K; Veski P; Kogermann K
Int J Pharm; 2015 Feb; 479(1):252-60. PubMed ID: 25549852
[TBL] [Abstract][Full Text] [Related]
6. Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions.
Yang C; Xu X; Wang J; An Z
Chem Pharm Bull (Tokyo); 2012; 60(7):837-45. PubMed ID: 22790815
[TBL] [Abstract][Full Text] [Related]
7. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
9. Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films.
Song Q; Guo X; Sun Y; Yang M
AAPS PharmSciTech; 2019 Aug; 20(7):273. PubMed ID: 31385126
[TBL] [Abstract][Full Text] [Related]
10. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
11. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
Al-Hamidi H; Obeidat WM; Nokhodchi A
Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
[TBL] [Abstract][Full Text] [Related]
12. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
Wu K; Li J; Wang W; Winstead DA
J Pharm Sci; 2009 Jul; 98(7):2422-31. PubMed ID: 18972575
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling.
Al-Hamidi H; Edwards AA; Douroumis D; Asare-Addo K; Nayebi AM; Reyhani-Rad S; Mahmoudi J; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Mar; 103():189-99. PubMed ID: 23201737
[TBL] [Abstract][Full Text] [Related]
14. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
[TBL] [Abstract][Full Text] [Related]
15. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.
Medarević DP; Kachrimanis K; Mitrić M; Djuriš J; Djurić Z; Ibrić S
Pharm Dev Technol; 2016; 21(3):268-76. PubMed ID: 25582577
[TBL] [Abstract][Full Text] [Related]
16. pH-independent dissolution enhancement for multiple poorly water-soluble drugs by nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates.
Tran CTM; Tran PHL; Tran TTD
Drug Dev Ind Pharm; 2019 Mar; 45(3):514-519. PubMed ID: 30575412
[TBL] [Abstract][Full Text] [Related]
17. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
18. A comparative study on the effects of amphiphilic and hydrophilic polymers on the release profiles of a poorly water-soluble drug.
Irwan AW; Berania JE; Liu X
Pharm Dev Technol; 2016 Mar; 21(2):231-8. PubMed ID: 25496001
[TBL] [Abstract][Full Text] [Related]
19. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers.
Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH
Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546
[TBL] [Abstract][Full Text] [Related]
20. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]